PlainRecalls

Keryx Biopharmaceuticals, Inc.

Compiled from official public sources by the publisher.

2 recalls on record · Latest: Jul 22, 2020

Subscribe to new Keryx Biopharmaceuticals, I… recalls (RSS)

Agency notice ledger

Federal filing book Keryx Biopharmaceuticals, I… LIGHT-BOOK · SINGLE-AGENCY

#5,144 of 14,151 · 2 notices · 0.002% archive

  • BOOK 2 notices
  • RANK #5,144 of 14,151
  • SHARE 0.002% archive
  • AGENCY FDA Drug (2)
  • CAT children
  • CATS 1 category
  • LATEST Jul 22, 2020
  • PHOTO 3M Company

Nearest notice-volume peer: 3M Company (0 notice gap)

Keryx Biopharmaceuticals, Inc. accounts for about 0.002% of the 104,423-notice archive on 2 distinct filings — a light share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

How Keryx Biopharmaceuticals, I… compares to 14,151 recalling firms

Keryx Biopharmaceuticals, Inc. ranks 5,144th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Keryx Biopharmaceuticals, I… vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

2 5144th of 14151 higher than 8,037 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-14

Keryx Biopharmaceuticals, I… in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Keryx Biopharmaceuticals, Inc. holds about 0.002% of archive notices alongside 2 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Moderate Jul 22, 2020

Auryxia (ferric citrate) tablets 210 mg, Rx Only, 200 tablets per bottle, Manufactured for and distributed by: Keryx Biopharmaceuticals, Inc., 245 First Street Suite 1400, Cambridge, MA 02142, NDC: 59922-631-01.
FDA Drug Low Jan 3, 2018

Auryxia (ferric citrate) tablets, 210 mg , 200-count bottles, RX ONLY, Manufactured for and distributed by: Keryx Biopharmaceticals, Inc. One Marina Park Drive, 12th Floor, Boston, MA 02210 USA. NDC 59922-631-01

Keryx Biopharmaceuticals, I… is a small archive contributor

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Similar children volume

Nearest multi-notice firms in the same narrow category lane.

Adam's Polishes LLC 2 Alliance Chemical, of Taylor, Texas 2 Anatox Inc 2 Aqua Filter Fresh, Inc. 2

Frequently Asked Questions

How many federal recall notices name Keryx Biopharmaceuticals, I…? ▼
PlainRecalls indexes 2 distinct federal recall events naming Keryx Biopharmaceuticals, Inc., aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Keryx Biopharmaceuticals, I… sit among other recalling firms? ▼
Keryx Biopharmaceuticals, Inc. ranks #5,144 of 14,151 by distinct recall-event count among 14,151 firms in this archive (57th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Keryx Biopharmaceuticals, I…'s notices? ▼
FDA Drug accounts for 2 of this firm's 2 indexed notices.
What product category dominates Keryx Biopharmaceuticals, I…'s filing book? ▼
Filings for Keryx Biopharmaceuticals, Inc. span 1 product category, led by children. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Keryx Biopharmaceuticals, Inc.: 2 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Keryx Biopharmaceuticals, Inc.; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026